Study at a glance
What was studied?
Researchers investigated whether vitamin D changes how the body uses sugar and fat. They studied people, animals and cells. Some studies measured fuel use directly. Others measured insulin responses or activity inside cells.
What did the studies find?
One human trial found an improved laboratory insulin response. Other trials found no clear advantage or had uncertain results. In a small study, the liver responded differently from the overall measurement of glucose removal. Lower vitamin D was not always linked to lower cell activity.
What does this mean?
A better insulin test does not automatically mean better switching between sugar and fat. Body fat can also affect the vitamin D result measured in blood. The direction of that relationship matters when interpreting an association.
What are the limits?
Many studies were small or measured only one part of metabolism. Animal and cell results do not prove a benefit from supplements in people. The evidence does not establish a personal dose, a blood target or a dependable improvement in fuel switching.
Read the full article below ↓Vitamin D research gives a mixed picture of fuel use and insulin responses. Some experiments find changes, but different studies measure different parts of metabolism. This summary explains why the findings cannot all be called improved fuel switching. For the detailed comparisons and source limitations, read Vitamin D, Fuel Switching and Insulin Sensitivity: Full Evidence Review.
Fuel use is not the same as fuel switching
Metabolic flexibility is the ability to change fuel use when conditions change, such as after a meal. Using sugar or fat at one moment is different from changing between them. The overview Vitamin D and Metabolic Flexibility explains that distinction in a wider physiological setting.
Zhang and colleagues measured energy use in 69 young, healthy adults inside a metabolic chamber. They did not detect clear differences in carbohydrate or fat oxidation between vitamin D status groups. However, participants were not randomly assigned to those groups. The study cannot prove that vitamin D never affects metabolism, and it did not establish a defined fasting-to-feeding switching response.
Petchey and colleagues tested vitamin D3 against placebo for six months in 28 adults with chronic kidney disease; 25 contributed the analysed outcomes. The study combined controlled insulin testing with estimates of fuel oxidation. It found no clear treatment advantage in glucose disposal or fuel handling. Most participants began with relatively sufficient vitamin D status, so the result cannot settle every deficiency setting.
A separate Pathak report described a positive association after a glucose challenge. This is included only as qualitative abstract-level background because its complete material results were unavailable for appraisal. It is not evidence that supplements caused the response.
Insulin findings differ between trials and tissues
Insulin helps regulate glucose handling. A laboratory improvement in insulin response does not necessarily mean better blood glucose control or better fuel switching. These related processes are introduced in Vitamin D and Insulin Signalling and Vitamin D and Glucose Homeostasis.
Lemieux and colleagues randomly assigned 96 adults at high diabetes risk or with newly diagnosed diabetes. After six months, vitamin D3 improved the main clamp-based insulin-sensitivity measure compared with placebo. A clamp tests glucose handling under controlled conditions. Other estimates and glycaemic outcomes did not show clear treatment effects, and recruitment fell short of the intended size. The trial did not demonstrate diabetes prevention or measure fuel switching directly.
Cefalo and colleagues analysed 18 people receiving vitamin D3 or placebo alongside a calorie-restricted diet. The vitamin D group improved from its own starting point, but the comparison of changes between groups was not conclusive. Participant losses and an inconsistency in the allocation counts weaken interpretation. A subgroup defined by the vitamin D level reached after treatment cannot establish an optimal target.
Lontchi-Yimagou and colleagues studied 19 adults and found an improved liver insulin response without a clear overall advantage in glucose disposal. Changes in fat-tissue markers did not establish that reduced inflammation caused the human result. Their separate mouse receptor experiment was a different intervention from giving people vitamin D3.
Cell activity and body fat add important qualifications
Calton and colleagues found higher oxygen use in blood immune cells from adults with lower vitamin D status. That did not mean those cells produced energy more efficiently. Chang and Kim found changes in lipid accumulation and energy-related markers in muscle-cell and rat experiments, but did not directly measure dynamic fuel switching. The physiological context is described in Vitamin D and Mitochondrial Function; the experimental measurements cannot substitute for a demonstrated human benefit.
Mousa and colleagues’ inflammatory trial randomly assigned 65 people, with 54 completing the analysis. Raising vitamin D did not clearly improve the measured inflammatory markers. The same trial’s primary insulin paper reported a null result, used here only as qualitative abstract-level background because its complete material tables were not inspected. The two papers are not independent trials.
Vimaleswaran and colleagues used genetic evidence to investigate direction. Their findings supported higher body mass index contributing to lower vitamin D status more clearly than the reverse direction. Genetic assumptions and population limits remain important. A low vitamin D blood result alongside higher body fat therefore does not by itself show that vitamin D deficiency caused the body fat.
Kang and Wong also reported opposing metabolic contexts involving the vitamin D receptor. They are retained only as qualitative abstract-level background, without numerical or detailed robustness claims. Manipulating a receptor in an experimental model is not the same as taking a supplement.
What can be concluded?
The selected evidence includes a positive insulin-sensitivity trial, null or uncertain clinical comparisons, and biological mechanisms worth distinguishing carefully. It does not establish a reliable supplement-induced improvement in sugar-to-fat switching, universal mitochondrial efficiency or a personal vitamin D target. A change in one laboratory measurement is not proof of an improvement in all aspects of metabolism.
The full review explains the source-specific access limits, participant-flow discrepancies and shared-trial relationships. This summary does not treat unavailable figures or supplements as inspected. Petchey’s author-list erratum adds Emma L. Duncan and does not provide a new efficacy result. The four expressly labelled background reports do not count as additional fully appraised studies.
Sources
Related reading
Association between vitamin D status and insulin resistance in Korean adolescents: differential effects of obesity using non-insulin-based indices
This study evaluated the relationship between vitamin D status and insulin resistance (IR) among Korean adolescents, focusing on the differences between normal-weight and overweight/obese groups using non-insulin-based IR indices.
Original paper ↗Read more →Optimal vitamin D supplement dosage for improving insulin resistance in children and adolescents with overweight/obesity: a systematic review and network meta-analysis
Our network meta-analysis of 15 RCTs suggested that, compared with placebo and LDS, EHDS was increased 25-(OH)-D, with a pooled MD of 8.65 (95% CI 4.72 to 12.58) and 7.66 (95% CI 0.91 to 14.41), respectively.
Original paper ↗Read more →Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial
Yet, no trials have examined the effects of vitamin D supplementation on NFκB activity in-vivo in humans.
Original paper ↗Read more →Vitamin D Ameliorates Fat Accumulation with AMPK/SIRT1 Activity in C2C12 Skeletal Muscle Cells
The purpose of present study is to investigate a role of vitamin D in muscle fat accumulation and mitochondrial changes.
Original paper ↗Read more →Vitamin D, Fuel Switching and Insulin Sensitivity: Full Evidence Review
Compare human trials and cell studies of vitamin D, fuel use and insulin sensitivity.
Read more →Hypothesized pathways for the association of vitamin D status and insulin sensitivity with resting energy expenditure: a cross sectional mediation analysis in Australian adults of European ancestry
The role of vitamin D in human energy expenditure requires confirmation.
Original paper ↗Read more →Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease
NAFLD patients and healthy participants (n = 91 each) were enrolled.
Original paper ↗Read more →A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome
Forty women with PCOS were recruited and randomized to vitamin D (3200 IU) or placebo daily for 3 months.
Original paper ↗Read more →Improvement in Symptoms of Depression and Anxiety and Cardiometabolic Risk Factors in Children and Adolescents with Overweight and Obesity Following the Implementation of a Multidisciplinary Personalized Lifestyle Intervention Program
Childhood obesity is one of the most challenging contemporary public health problems.
Original paper ↗Read more →Prevalence of hyperuricemia and its associations with hyperinsulinemia and hepatic injury among adolescents with obesity in Guangxi, China
To investigate the prevalence of hyperuricemia (HUA) in adolescents with obesity in Guangxi, southern China, and explore its associations with hyperinsulinemia and hepatic injury.
Original paper ↗Read more →Additional treatment of vitamin D for improvement of insulin resistance in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis
This study aimed to evaluate the effect of additional treatment of vitamin D for the improvement of insulin resistance in NAFLD patients.
Original paper ↗Read more →Dietary Composition and Its Association with Newly Diagnosed Nonalcoholic Fatty Liver Disease and Insulin Resistance
Participants took photographs of their meals and documented their food intake in a food diary for seven consecutive days.
Original paper ↗Read more →Adherence to the dietary index for gut microbiota and the 5-year incidence of metabolic dysfunction-associated steatotic liver disease in Iranian adults: a prospective cohort study
The five-year incidence of MASLD was evaluated using multivariable logistic regression models, and associations were expressed as odds ratios (ORs) with 95% confidence intervals (CIs).
Original paper ↗Read more →Aerobic training with moderate or high doses of vitamin D improve liver enzymes, LXRα and PGC-1α levels in rats with T2DM
The D + AT + HD and D + AT + MD groups had lower levels of ALT and AST enzymes compared to the other groups with no significant difference between D + AT + HD and D + AT + MD.
Original paper ↗Read more →Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
The nonalcoholic fatty liver disease patients were randomized into two groups: treated (60 patients) and not treated (30 patients).
Original paper ↗Read more →Maternal Vitamin D Deficiency During Pregnancy Alters Hepatic Metabolism in Adult Female Offspring Without Overt Metabolic Dysfunction
This study aimed to comprehensively assess hepatic metabolic profiles in female offspring exposed to maternal VDD during gestation.
Original paper ↗Read more →Role of Vitamin D Supplementation in Chronic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Our aim was to evaluate the effects of vitamin D supplementation in patients with chronic liver disease by conducting a systematic review and meta-analysis of randomized controlled trials (RCTs).
Original paper ↗Read more →Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes
Aim of our study was to test the hypothesis of a direct association between hypovitaminosis D and the presence of NAFLD in subjects with various degree of insulin-resistance and related metabolic disorders.
Original paper ↗Read more →Temporal gut microbiota dysbiosis links metabolic impairment, LDL desialylation, and accelerated atherosclerosis in LDLR−/− mice
Male C57BL/6J wild-type and LDLR−/− mice were fed either a normal diet (ND) or HCD for 12 weeks, with gut microbiota profiled at weeks 0, 8, and 12.
Original paper ↗Read more →The effect of vitamin D supplementation on some metabolic parameters in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of 8 RCTs
Eight randomized controlled trials with a total of 657 patients are included.
Original paper ↗Read more →The Effects of Eight Weeks’ Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity
Herein, we evaluated the efficacy and safety of a VLCKD on non-alcoholic fatty liver disease (NAFLD) and parameters commonly associated with this condition in overweight and obese subjects who did not take any drugs.
Original paper ↗Read more →Original sources
25-Hydroxyvitamin D status does not affect energy metabolism among young, healthy, non-obese adults: a metabolic chamber study
Published in Zhang L, Cai H, Bai X, Xiao W, Cao Z-B, Zhang Y (2024). Frontiers in Endocrinology15:1501818. DOI10.3389/fendo (2024).
Publication details
25-Hydroxyvitamin D status does not affect energy metabolism among young, healthy, non-obese adults: a metabolic chamber study. Zhang L, Cai H, Bai X, Xiao W, Cao Z-B, Zhang Y (2024). Frontiers in Endocrinology15:1501818. DOI10.3389/fendo.2024.1501818; PMID39624819; PMC11608976. DOI: 10.3389/fendo.2024.1501818. PMID: 39624819.
Vitamin D Ameliorates Fat Accumulation with AMPK/SIRT1 Activity in C2C12 Skeletal Muscle Cells
The purpose of present study is to investigate a role of vitamin D in muscle fat accumulation and mitochondrial changes.
Publication details
Vitamin D Ameliorates Fat Accumulation with AMPK/SIRT1 Activity in C2C12 Skeletal Muscle Cells. Chang E, Kim Y (2019). Nutrients11(11):2806. DOI10.3390/nu11112806; PMID31744213; PMC6893473. DOI: 10.3390/nu11112806. PMID: 31744213.
Prevailing vitamin D status influences mitochondrial and glycolytic bioenergetics in peripheral blood mononuclear cells obtained from adults
Published in Calton EK, Keane KN, Soares MJ, et al. (2016). Redox Biology10:243 to 250. DOI10.1016/j.redox (2016).
Publication details
Prevailing vitamin D status influences mitochondrial and glycolytic bioenergetics in peripheral blood mononuclear cells obtained from adults. Calton EK, Keane KN, Soares MJ, et al. (2016). Redox Biology10:243 to 250. DOI10.1016/j.redox.2016.10.007; PMID27816874; PMC5097975. DOI: 10.1016/j.redox.2016.10.007. PMID: 27816874.
Insulin-sensitizing effects of vitamin D repletion mediated by adipocyte vitamin D receptor: Studies in humans and mice
Published in Lontchi-Yimagou E, Kang S, Goyal A, et al. (2020). Molecular Metabolism42:101095. DOI10.1016/j.molmet (2020).
Publication details
Insulin-sensitizing effects of vitamin D repletion mediated by adipocyte vitamin D receptor: Studies in humans and mice. Lontchi-Yimagou E, Kang S, Goyal A, et al. (2020). Molecular Metabolism42:101095. DOI10.1016/j.molmet.2020.101095; PMID33045433; PMC7585951. DOI: 10.1016/j.molmet.2020.101095. PMID: 33045433.
Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial
Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial.
Publication details
Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial. Cefalo CMA, Conte C, Sorice GP, et al. (2018). Obesity26(4):651 to 657. DOI10.1002/oby.22132; PMID29504254; PMC6175391. DOI: 10.1002/oby.22132. PMID: 29504254.
Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial
Yet, no trials have examined the effects of vitamin D supplementation on NFκB activity in-vivo in humans.
Publication details
Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial. Mousa A, Naderpoor N, Johnson J, et al. (2017). Scientific Reports7:15154. DOI10.1038/s41598-017-15264-1; PMID29123173; PMC5680306. DOI: 10.1038/s41598-017-15264-1. PMID: 29123173.
Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts
Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts.
Publication details
Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. Vimaleswaran KS, Berry DJ, Lu C, et al. (2013). PLoS Medicine10:e1001383. DOI10.1371/journal.pmed.1001383; PMID23393431; PMC3564800. DOI: 10.1371/journal.pmed.1001383. PMID: 23393431.
Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial
Published in Petchey WG et al.. Nephrology (Carlton) (2013).
Publication details
Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial. Petchey WG et al.. Nephrology (Carlton). 2013;18(1):26-35. DOI: 10.1111/j.1440-1797.2012.01662.x. PMID: 23043683.
Effects of 6-month vitamin D supplementation on insulin sensitivity and secretion: a randomised, placebo-controlled trial
Published in Lemieux P et al.. European Journal of Endocrinology (2019).
Publication details
Effects of 6-month vitamin D supplementation on insulin sensitivity and secretion: a randomised, placebo-controlled trial. Lemieux P et al.. European Journal of Endocrinology. 2019;181(3):287-299. DOI: 10.1530/EJE-19-0156. PMID: 31344685.
Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status
Published in Pathak K et al.. Nutrition (2017).
Publication details
Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status. Pathak K et al.. Nutrition. 2017;37:37-42. DOI: 10.1016/j.nut.2016.12.007. PMID: 28359360. Qualitative abstract-level background only; not a fully appraised primary unit.
Vitamin D supplementation has no effect on insulin sensitivity or secretion in vitamin D-deficient, overweight or obese adults: a randomized placebo-controlled trial
Published in Mousa A et al.. American Journal of Clinical Nutrition (2017).
Publication details
Vitamin D supplementation has no effect on insulin sensitivity or secretion in vitamin D-deficient, overweight or obese adults: a randomized placebo-controlled trial. Mousa A et al.. American Journal of Clinical Nutrition. 2017;105(6):1372-1381. DOI: 10.3945/ajcn.117.152736. PMID: 28490514. Qualitative abstract-level background only; not a fully appraised primary unit.
Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis
Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis.
Publication details
Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis. Kang S, Tsai LT, Zhou Y, et al. (2015). Nature Cell Biology17(1):44 to 56. DOI10.1038/ncb3080; PMID25503565; PMC4281178. DOI: 10.1038/ncb3080. PMID: 25503565. Qualitative abstract-level background only; not a fully appraised primary unit.
Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice
Published in Wong KE et al.. Journal of Biological Chemistry (2011).
Publication details
Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice. Wong KE et al.. Journal of Biological Chemistry. 2011;286(39):33804-33810. DOI: 10.1074/jbc.M111.257568. PMID: 21840998. Qualitative abstract-level background only; not a fully appraised primary unit.